Derivation of germline competent rabbit embryonic stem cell lines

种系感受态兔胚胎干细胞系的衍生

基本信息

  • 批准号:
    8109847
  • 负责人:
  • 金额:
    $ 55.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-05 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The rabbit is a good animal model for the study of many human diseases because of its anatomical, genetic and biochemical similarities to the human. It is also used for drug screening, production of antibody and production of therapeutic proteins. The rabbit is large enough to provide adequate quantities of tissue for experimental work, produce sufficient amount of antibody or therapeutic proteins, and yet it is small enough to be economical for most laboratories. To date, pronuclear microinjection remains the primary method to produce transgenic rabbits. There are no germline competent rabbit embryonic stem (rbES) cell lines available. Pronuclear microinjection, however, is of low efficiency, results in random integration, and cannot produce gene targeted transgenic animals. The purpose of this SBIR project is to establish germline competent rbES cell lines for the production of gene targeted transgenic rabbits. In Phase I we established rabbit embryonic fibroblasts as feeder layers, synthesized recombinant rabbit leukemia inhibitory (LIF) factor, and derived putative rbES cells. In Phase II, we will work to validate if these rbES cells can contribute to germ line cells after blastocyst injection and we will work to produce gene targeted transgenic rabbits from these cells. Specific Aims in Phase II project include: (1) derive new rbES cell lines with inhibitors of differentiation; (2) evaluate germline competency of rbES cells; and (3) produce gene targeted transgenic rabbits. The success of this project will establish the first germline competent ES cell lines in a non-murine species, improve the transgenic efficiency in rabbits, and make the production of gene targeted rabbits possible. PUBLIC HEALTH RELEVANCE: The rabbit is a good animal model for the study of many human diseases because of its anatomical, genetic and biochemical similarities to the human. It is also used for drug screening, production of antibody and production of therapeutic proteins. The main reason that rabbit has not been in these fields is that there have been no established germline competent rabbit embryonic stem (rbES) cell lines. The success of this project will establish the first germline competent ES cell lines in a non-murine species, improve the transgenic efficiency in rabbits, and make the production of gene targeted rabbits possible.
描述(由申请人提供):由于其解剖学、遗传学和生物化学与人类相似,家兔是研究许多人类疾病的良好动物模型。它还用于药物筛选,抗体生产和治疗性蛋白质的生产。兔子足够大,可以为实验工作提供足够数量的组织,产生足够数量的抗体或治疗性蛋白质,但它又足够小,对大多数实验室来说是经济的。 目前,原核显微注射法仍是制备转基因兔的主要方法。没有可用的生殖系感受态兔胚胎干(rbES)细胞系。然而,原核显微注射效率低,导致随机整合,并且不能产生基因靶向的转基因动物。 本SBIR项目的目的是建立生殖系感受态rbES细胞系,用于生产基因靶向转基因兔。在第一阶段,我们建立了兔胚胎成纤维细胞作为饲养层,合成重组兔白血病抑制(LIF)因子,并衍生推定rbES细胞。 在第二阶段,我们将努力验证这些rbES细胞在囊胚注射后是否可以促进生殖系细胞,我们将努力从这些细胞中产生基因靶向转基因兔。II期项目的具体目标包括:(1)获得新的具有分化抑制剂的rbES细胞系;(2)评价rbES细胞的种系能力;(3)产生基因靶向转基因兔。本项目的成功将建立第一个非鼠源ES细胞系,提高兔的转基因效率,使基因靶向兔的生产成为可能。 公共卫生相关性:由于兔子与人类的解剖、遗传和生化相似,因此它是研究许多人类疾病的良好动物模型。它还用于药物筛选,抗体生产和治疗性蛋白质的生产。兔尚未进入这些领域的主要原因是尚未建立具有生殖系能力的兔胚胎干细胞系。本项目的成功将建立第一个非鼠源ES细胞系,提高兔的转基因效率,使基因靶向兔的生产成为可能。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Spatial and temporal distribution of Oct-4 and acetylated H4K5 in rabbit embryos.
  • DOI:
    10.1016/j.rbmo.2012.01.001
  • 发表时间:
    2012-04
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Chen CH;Chang WF;Liu CC;Su HY;Shyue SK;Cheng WT;Chen YE;Wu SC;Du F;Sung LY;Xu J
  • 通讯作者:
    Xu J
Recombinant rabbit leukemia inhibitory factor and rabbit embryonic fibroblasts support the derivation and maintenance of rabbit embryonic stem cells.
  • DOI:
    10.1089/cell.2012.0001
  • 发表时间:
    2012-08
  • 期刊:
  • 影响因子:
    1.6
  • 作者:
    F. Xue;Yinghong Ma;Y. E. Chen;Jifeng Zhang;T. Lin;Chien-Hong Chen;Wei-Wen Lin;M. Roach;J. Ju;Lan Yang;F. Du;Jie Xu
  • 通讯作者:
    F. Xue;Yinghong Ma;Y. E. Chen;Jifeng Zhang;T. Lin;Chien-Hong Chen;Wei-Wen Lin;M. Roach;J. Ju;Lan Yang;F. Du;Jie Xu
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fuliang Du其他文献

Fuliang Du的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fuliang Du', 18)}}的其他基金

Novel Transgenic Rabbit Model for Cardiovascular Disease
新型转基因兔心血管疾病模型
  • 批准号:
    7568584
  • 财政年份:
    2008
  • 资助金额:
    $ 55.54万
  • 项目类别:
Novel Transgenic Rabbit Model for Cardiovascular Disease
新型转基因兔心血管疾病模型
  • 批准号:
    7404671
  • 财政年份:
    2008
  • 资助金额:
    $ 55.54万
  • 项目类别:
Novel Transgenic Rabbit Model for Cardiovascular Disease
新型转基因兔心血管疾病模型
  • 批准号:
    7676033
  • 财政年份:
    2008
  • 资助金额:
    $ 55.54万
  • 项目类别:
Novel method to produce transgenic rabbits
生产转基因兔的新方法
  • 批准号:
    6834321
  • 财政年份:
    2004
  • 资助金额:
    $ 55.54万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 55.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了